Get the latest tech news
Therapeutic vaccine for chronic hepatitis B enters first clinical trial in patients
TherVacB, a novel therapeutic
TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich in collaboration with the German Center for Infection Research (DZIF), has entered its first clinical trial in patients. "This vaccine aims to activate the natural immune response in a way that could finally enable the body to eliminate the virus," adds Protzer, who also coordinates the research area " Hepatitis" in the DZIF. "The outcomes of this trial may not only shape future phases of clinical development but also redefine the global strategy for managing hepatitis B—especially in regions with high disease burden and limited access to existing treatments," says Michael Hoelscher.
Or read this on r/technology
